In this study, we examine the response of emerging stock markets due to the uncertainty of pandemics and epidemics (UPE), including the COVID-19 pandemic We demonstrate this by evaluating the stock return predictability of 24 emerging market stocks using the new datasets on uncertainty due to pandemics as well as the global fear index for the COVID-19 pandemic We partition the data sample into periods before and after the announcement of the COVID-19 pandemic and employ panel data techniques that account for salient features of both the series and predictive model We found that emerging stock markets are more vulnerable to UPE than developed market stocks Put differently, developed stock markets provide a better hedge against UPE than emerging stock markets We also find that incorporating the UPE indicator in the valuation of stocks, particularly during pandemics, is crucial for investment decisions
Pandemics and the emerging stock markets